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ABSTRACT 
Background/Aims It has been proposed that, in acute liver failure, skeletal muscle adapts to become the principle 
organ responsible for removal of blood-borne ammonia by increasing glutamine synthesis, a reaction that is 
catalyzed by the cytosolic ATP-dependent enzyme glutamine synthetase. To address this issue, glutamine synthetase 
expression and activities were measured in skeletal muscle of rats with acute liver failure resulting from hepatic 
devascularization. Methods Glutamine synthetase protein and gene expression were investigated using 
immunoblotting and semi-quantitative RT-PCR analysis. Glutamine synthetase activity and glutamine de novo 
synthesis were measured using, respectively, a standard enzymatic assay and [13C]-nuclear magnetic resonance 
spectroscopy. Results Glutamine synthetase protein (but not gene) expression and enzyme activities were 
significantly up-regulated leading to increased de novo synthesis of glutamine and increased skeletal muscle 
capacity for ammonia removal in acute liver failure. In contrast to skeletal muscle, expression and activities of 
glutamine synthetase in the brain were significantly decreased. Conclusions These findings demonstrate that 
skeletal muscle adapts, through a rapid induction of glutamine synthetase, to increase its capacity for removal of 
blood-borne ammonia in acute liver failure. Maintenance of muscle mass together with the development of agents 
with the capacity to stimulate muscle glutamine synthetase could provide effective ammonia-lowering strategies in 
this disorder. 
Keywords Acute liver failure; Skeletal muscle; Ammonia; Glutamine; Glutamine synthetase; Nuclear magnetic 
resonance spectroscopy; Brain edema 
INTRODUCTION 
Circulating ammonia concentrations in the 250–600 μM range have consistently been reported in both experimental 
and human acute liver failure (ALF) and increased arterial ammonia concentrations have been proposed as a 
predictor of brain herniation and mortality in ALF patients [1]. Brain ammonia may reach millimolar concentrations 
in ALF and such concentrations are well established to have deleterious effects on cerebral metabolism and function 
[2]. 
Under normal physiological conditions, ammonia detoxification relies almost exclusively on hepatic urea and 
glutamine synthesis by periportal and perivenous hepatocytes, respectively. ALF resulting from either toxic liver 
injury or viral hepatitis results in a serious compromise of hepatocyte integrity with consequent increases of 
circulating ammonia. A number of studies have provided evidence that skeletal muscle becomes the major organ 
responsible for removal of excess blood-borne ammonia in cirrhotic patients [3] as well as in animal models of 
chronic liver failure [4] and [5]. However, evidence that a similar response occurs in ALF is limited. 
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The objective of the present study was the assessment of the capacity of skeletal muscle compared to brain (a second 
organ with the potential to remove ammonia) to increase its capacity to remove increased blood-borne ammonia in 
ALF. Four approaches based upon molecular, spectroscopic and hemodynamic measurements were undertaken 
namely (1) Measurement of glutamine synthetase (GS) mRNA and protein, (2) measurement of GS enzyme activities, 
(3) measurement of ammonia and glutamine metabolic fluxes and (4) direct spectroscopic measurement of de novo 
glutamine synthesis in experimental ALF. The devascularized rat model of ALF was used for the studies described 
since this model recapitulates the pathologic, metabolic and neurologic features of human ALF including sustained 
hyperammonemia, loss of perivascular and periportal hepatocytes and neurological manifestations such as brain 
edema and encephalopathy [6]. Studies were undertaken 6 h following hepatic devascularization, prior to the onset 
of brain edema or severe encephalopathy in order to minimize confounding effects of these complications on 
cerebral metabolism. 
MATERIAL AND METHODS 
Animal surgery 
Male Sprague–Dawley rats (175–200 g) were anesthetized with isoflurane, and an end-to-side portacaval 
anastomosis was performed according to the guidelines of Lee and Fisher [7] and as previously described [8]. Total 
surgery time was <15 min. Sham-operated control rats, matched for weight, were similarly anesthetized and the 
portal vein was clamped for 15 min. Following surgery, all animals were individually housed with free access to food 
and water under constant conditions of temperature, humidity, and light cycles. 
Twenty-four hours after portacaval anastomosis or laparotomy, rats were reanesthetized and subjected to hepatic 
artery ligation (HAL) and all animals were sacrificed 6 h after HAL. All surgical procedures were performed in 
accordance with the Guidelines of Canadian Council of Animal care and were approved by Animal Research 
Committee of CHUM. 
Measurement of organ blood flow 
Six hours post-HAL or sham operation, animals were anesthetized with isoflurane and body temperature was 
maintained at 37 °C with a CMA 150 temperature controller (CMA microdialysis, Stockholm, Sweden). A PE-10 
catheter (Intramedic Clay Adams, Becton Dickinson, Sparks, MD) was placed in the right carotid artery and advanced 
into the left ventricle as previously described [9]. Correct positioning in the left ventricle was verified by 
hemodynamic monitoring. A PE-50 catheter (Intramedic Clay Adams, Becton Dickinson, Sparks, MD) was placed in 
the left femoral artery. Total time for catheter placement was less than 15 min. 
Blood flow was measured using the radioactive microsphere technique as previously described [10]. Before sacrifice 
1–1.2×105 microspheres (15±2 μm) labeled with 85Sr (Perkin–Elmer, Boston, MA) in 0.7 mL of saline 0.05% tween 
80 (Sigma Aldrich, St Louis, MO) were sonicated for 30 min and injected over a 15 s period into the left ventricle to 
determine the hind limb muscle blood flow. Just before injection, withdrawal of blood from the femoral arterial 
catheter was started at a rate of 0.786 mL/min (Harvard pump, Mills, MA) and collected in a heparinized glass 
syringe for a total time of 1.25 min. 
At sacrifice, left and right kidneys, and right hind limb muscles (posterio-medial and lateral thigh, muscles) were 
rapidly removed, weighed, pooled and counted. Right and left renal blood flow and skeletal muscle flow were 
calculated from the radioactivity measured in those tissues using a gamma counter according to the formula 
described previously [11] 
Agreement between right and left kidney flow (≤20% difference) indicated adequacy of the microsphere injection. 
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Tissue sampling for arterio-venous differences 
Following the microsphere procedure, femoral veins and arteries of the right hind limb were exposed, arterial and 
venous blood samples were taken by heparinized syringes (1 mL, 25G needle). Arterial and venous blood of 0.5 mL 
was taken and immediately centrifuged to separate the plasma for determination of arterio-venous differences for 
ammonia and glutamine across the right hind limb. 
Measurement of plasma ammonia 
Plasma ammonia levels were measured using a commercial ammonia test kit, based on an ion exchange method, 
followed by colorimetric measurement of ammonia nitrogen with the Bertholet phenate-hypochlorate reaction [12]. 
Measurement of plasma glutamine 
Glutamine concentrations were measured in femoral arterial and venous plasma samples using a Perkin–Elmer 
reverse phase HPLC system with fluorescence detection and precolumn o-phthalaldehyde derivatization, as 
previously described [13]. 
Measurement of tissue glutamine synthetase activity 
Groups of rats were sacrificed by decapitation. Brains were rapidly removed and dissected on ice and 1 g of posterio-
medial and lateral thigh muscle was snap frozen. All tissue samples were stored at −70 °C until use. Glutamine 
synthetase (EC6.3.1.2) activity was measured in tissue homogenates as previously described with minor 
modifications [14]. Briefly, cerebral cortical and skeletal muscle samples were homogenised (20 wt%/vol) using a 
Teflon pestle in Tris-EDTA buffer (pH 7.4), and homogenates were centrifuged at 10,000g for 10 min. The 
supernatant (0.1 mL) was preincubated at 37 °C for 10 min in an assay mixture containing 100 mM imidazole (pH 
7.2), 12.5 mM MgCl2, 20 mM mercaptoethanol, 10 mM ATP, 4 mM ammonium chloride, 13 mM 
phosphoenolpyruvate, 50 units of pyruvate kinase and 0.16% Triton X-100. The reaction was started by adding 2 μCi 
of [1-14C]-glutamate (specific activity 60 mCi/mmole, Perkin–Elmer, Boston, MA) diluted with cold glutamate to a 
final concentration of 50 mM for skeletal muscle and 20 mM for cerebral cortex. After incubation at 37 °C for 60 min 
(30 min for muscle) the reaction was terminated by adding 1 mL ice-cold water and the mixture was immediately 
passed through a column (3 cm×0.7 cm) containing anion exchange resin (Dowex AG-1X8, acetate form). [1-14C]-
glutamate was quantitatively retained on the ion exchange column. Protein content of homogenates was determined 
by the method of Lowry [15]. Enzyme activities were expressed as micromoles of glutamine formed per hour per 
milligram of protein. 
GS gene expression (RT-PCR) 
RNA extraction 
Total RNA was extracted using TRI Reagent (MRC Inc., Ohio) according to the manufacturer's protocol. Putative 
contaminating DNA was eliminated by adding 100 U of RNase-free DNase I per 50 μg of total RNA at 37 °C for 1 h. 
Purified RNA was then extracted with phenol, precipitated with ethanol and resuspended in diethylpyrocarbonate-
treated water. RNA samples were stored at −70 °C until use. 
RT-PCR analysis 
Glutamine synthetase expression was measured by the reverse transcription-polymerase chain reaction (RT-PCR) 
using the same forward and reverse primer sequences and reactions conditions as previously described [5]. 
GS protein analysis (Western Blot) 
Tissue samples were homogenised in RIPA buffer (50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 0.1% SDS, 1% Triton X-
100, 0.5% sodium deoxycholate), and a protease inhibitor mixture consisting of 1 mM EDTA, 0.1 μM pepstatin A, 
1 μg/ml leupeptin, 1 μg/ml aprotinin, and 100 μg/ml phenylmethyl-sulfonyl fluoride. After centrifugation at 12,000g 
for 15 min, samples (50 μg protein) were boiled for 10 min in loading buffer (50 mM Tris–HCl, pH 6.8, 10% glycerol; 
2% SDS, 0.1 M dithiothreitol, 0.1% bromophenol blue). Proteins were resolved by 8% denaturing SDS-
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polyacrylamide gels and transferred overnight to nitrocellulose filters. Ponceau staining was used to ensure equal 
protein loading. The membranes were blocked for 2 h in Tris-buffered saline containing 5% dried milk and 0.1% 
Tween 20 (TBST), then incubated for 1 h with a monoclonal antibody directed against rat GS (Transduction 
laboratories, Lexington, KY). Blots were subsequently probed with anti-mouse horseradish peroxidase-conjugated 
antiserum (Roche Diagnostics, Indianapolis, IN) diluted 1/12,000 in the same buffer. After extensive washing with 
TBST, the peroxidase activity was detected by chemiluminescence using the Renaissance detection system (Perkin–
Elmer, Boston, MA) and quantified by densitometric scanning. 
1H13C Nuclear magnetic resonance spectroscopic studies 
Groups of hepatic devascularized rats 6 h post-HAL and their paired sham-operated controls were administered [U-
13]C-glucose (400 mg/kg, i.p.; Cambridge Isotope Laboratories, Andover, USA) and were killed exactly 20 min later by 
decapitation. Arterial blood glucose levels were continuously monitored and measured by mean of a glucometer 
using the glucose dehydrogenase method. Glucose was administered subcutaneously as needed to maintain 
normoglycemia. Immediately after sacrifice, samples of posterio-medial and lateral thigh muscle were snap-frozen, 
powdered over liquid nitrogen, and homogenized in 15 mL of a 12% PCA solution at 0 °C using a motor-driven 
polished glass tube-Teflon pestle homogenizer. The homogenate was centrifuged at 40,000g for 15 min; the 
supernatants were placed in an ice bath, and neutralized to pH 7.0 with KOH. The precipitated KClO4 was sedimented 
by centrifugation (40,000g for 15 min), and supernatants were lyophilized. The lyophilized PCA extracts of muscle 
tissue were redissolved in 0.6–0.8 ml deuterium oxide (D2O) and centrifuged. Prior to analysis the pH was adjusted 
to 7.0 with deuterium chloride (DCl) and NaOD. 1H- and 13C NMR spectra were recorded on Bruker DRX 600 or AMX 
360/AM 360 spectrometers, operating at frequencies of 600 or 360 MHz for 1H, and 150.9 or 90.5 MHz for 13C 
measurements. 
1H NMR spectra were recorded with a 5-mm H,C,N inverse triple resonance probe, 400 accumulations, repetition 
time 15 s, spectral width 7183 Hz (DRX 600) or 3623 Hz (AM/AMX 360), data size 16 K, zero filling to 32 K. Chemical 
shifts were referenced to lactate at 1.33 ppm. 
13C NMR spectra were recorded with a 5-mm 1H/13C dual probe, 10,000 accumulations, repetition time 2.5 s, 
composite pulse decoupling with WALTZ-16, spectral width 47,619 Hz (DRX 600) or 20,833 Hz (AM/AMX 360), data 
size 32 K (16 K), zero filling to 64 K (32 K). Chemical shifts were referenced to the C-3 signal of lactate at 21.3 ppm. 
Glutamine concentrations (μmol/g tissue) were determined from fully relaxed 1H NMR spectra of muscle extracts 
using (trimethylsilyl)propionic-2,2,3,3,d4-acid as an external standard. Fractional enrichment in glutamine (C3 
position) a measure of de novo glutamine synthesis was calculated from 13C NMR spectra as previously described 
[16]. 
Statistical analysis of data 
Data were analyzed by unpaired t-test. In cases where the variances between compared groups were significantly 
different, the unpaired t-test was modified with Welch's correction. The data were considered to be significantly 
different at P<0.05. 
RESULTS 
Effect of ALF on plasma ammonia and glutamine levels 
Plasma ammonia and glutamine levels in ALF rats are shown in Table 1. ALF resulted in a significant 16.5-fold 
(P<0.001) increase of arterial ammonia levels 6 h post-HAL compared to sham-operated control values. Arterial 
glutamine levels were concomitantly increased 6.7-fold (P<0.001) in the ALF animals. 
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Table 1. Arterial plasma levels, A–V differences, muscle ammonia and glutamine fluxes, and hemodynamics in the 
hind limb of rats with acute liver failure compared to sham-operated controls 
 
 
 
 
 
 
Values represent mean±SEM of eight rats per treatment group. Values significantly different from sham-operated 
group are indicated by: *P<0.01 and **P<0.001. 
Effect of ALF on GS gene expression, protein and activity in skeletal muscle and brain  
ALF resulted in a significant increase of GS protein in skeletal muscle (Fig. 1A and B) and a small but significant loss 
of GS protein in brain (frontal cortex) 6 h post-HAL compared to sham-operated controls (P<0.05). GS mRNA was 
unchanged following ALF (data not shown). 
 
 
 
 
 
 
Fig. 1. GS protein and enzyme activities in brain (cerebral cortex) and skeletal muscle of rats with ALF. (A) 
Representative Western blots of GS (45 kDa) from two ALF rats compared to sham-operated controls. (B) GS protein 
data from n=8 animals per treatment group. (C) GS enzyme activities determined in cerebral cortex and skeletal 
muscle of eight ALF rats compared to eight sham-operated controls. Values represent mean±SE, * indicates values 
significantly different from sham-operated control values (P<0.05). 
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Changes in GS enzyme activities paralleled those of GS protein: ALF resulted in a 38% increase (P<0.05) in GS 
enzyme activities in skeletal muscle 6 h post-HAL (Fig. 1C). In contrast, a small but significant loss (P<0.05) of GS 
activity was observed in the cerebral cortex of ALF animals at the same time point. 
Arterio-venous differences across skeletal muscle of ALF rats 
Sham operated control rats manifested significantly lower ammonia concentrations in the femoral vein compared to 
the femoral artery leading to an A–V difference of 19.8±5.8 μM. This A–V difference was increased five-fold 6 h post-
HAL in the HAL group (103.9±14.2 μM; P<0.001) (Table 1). These positive A–V differences for ammonia across the 
hind limb of control animals were accompanied by a significant release of glutamine (A–V difference of 
−84.5±20.9 μM). This A–V difference for glutamine was significantly increased 5-fold 6 h post-HAL in the ALF group 
(−431.8±75.6 μM, P<0.01) (Table 1). 
Effect of ALF on muscle blood flow and on fluxes of glutamine and ammonia across the 
hind limb 
Values for muscle blood flow are presented in the Table 1. Variation of renal blood flow between the right and left 
kidney were less than 20% and differences between the two treatment groups were not significant indicating that 
the procedure used was valid. There was a significant 188% (P<0.01) increase in muscle blood flow 6 h post-HAL 
compared to sham operated control values. 
Uptake of ammonia across the hind limb was significantly increased in ALF rats compared to sham-operated controls 
(2.76±0.51 μmol/min per 100 g of muscle versus 0.22±0.11 μmol/min per 100 g; P<0.01) (Table 1). Glutamine 
release by the hind limb was concomitantly increased from −0.91±0.33 μmol/min per 100 g of tissue in control rats 
to −12.18±2.22 μmol/min per 100 g of tissue in ALF rats (P<0.001). 
Effect of ALF on de novo glutamine synthesis in skeletal muscle 
1H/13C NMR measurements revealed a significant 73.4% (P<0.0001) increase in muscle glutamine levels 6 h post-
HAL compared to sham-operated controls (Fig. 2A and B). Increased muscle glutamine levels were accompanied by 
significant 61% (P<0.01) increase in 13C glutamine labeling from [U–13C]glucose indicating increased de novo 
glutamine synthesis (Fig. 2B). 
Fig. 2. Muscle glutamine concentrations and de novo glutamine 
synthesis from [U–13C]-glucose in rats with ALF compared to sham-
operated controls measured by 1H/13C NMR. (A) Representative 13C-
spectra of muscle extracts, Gln C3, glutamine labeled in position C3; 
Glu C3, glutamate labeled in position C3. The singlet in the C3 
glutamine peak position represents the natural abundance of 13C in 
unlabeled glutamine and monolabeled glutamine. The doublet 
(dashed lines) represents double-labeled [2,3-13C]-glutamine 
synthesized de novo from [U–13C]-glucose in the TCA cycle. (B) 
Muscle glutamine concentration and its de novo synthesis (13C 
enrichment in C3 glutamine) from glucose in ALF rat muscle 
compared to sham-operated controls. Values represent mean±SE 
from six rats per treatment group. * Indicates values significantly 
different from sham-operated control P<0.0001. 
Chatauret, N. et al., 2006. Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle 
in acute liver failure. Journal of Hepatology, 44(6), p.1083-1088.  
The final publication is available at http://dx.doi.org/10.1016/j.jhep.2005.11.048 
DISCUSSION 
Results of the present study provide the first unequivocal evidence in support of the notion that skeletal muscle 
ammonia removal capacity is increased in ALF. This increase occurs as a consequence of an early post-
transcriptional increase in expression of glutamine synthetase (GS) a cytosolic enzyme (Fig. 3) that is predominantly 
responsible for ammonia removal by skeletal muscle which is devoid of an effective urea cycle. Glutamine synthetase 
activities were increased by 40% early during the progression of ALF and 13C Nuclear Magnetic Resonance 
Spectroscopic studies revealed that this led to a significant increase in de novo synthesis of glutamine by skeletal 
muscle. These findings confirm and extend those of a previous study based upon a report of increased ammonia 
removal and glutamine release in the femoral vein in patients with ALF [17]. 
 
 
Fig. 3. Schematic representation of the glutamine synthesis reaction in muscle and brain. 
In the present study, induction of GS protein and enzyme activities led to a significant decrease in arterio-venous 
differences for glutamine. Muscle blood flow was concomitantly increased 2.7-fold consistent with the well-
established hyperdynamic circulation characteristic of ALF. An accurate measurement of muscle ammonia and 
glutamine fluxes requires measurement of arterio-venous differences corrected for change in organ blood flow. Such 
a computation in the present study reveals a 12-fold uptake of ammonia and a corresponding increase of muscle 
glutamine release from skeletal muscle. That these findings represent principally increased glutamine synthesis in 
skeletal muscle was confirmed by studies with 13C NMR which showed unequivocally that de novo synthesis of 
glutamine was significantly increased. However, since glutamine de novo synthesis is less than total glutamine 
release from muscle, synthesis of glutamine from other sources of carbon than glucose or muscle protein breakdown 
cannot be ruled out. 
In contrast to skeletal muscle, results of the present study clearly demonstrate that, GS protein expression and 
enzyme activities in brain manifest small but statistically significant reductions 6 h following hepatic 
devascularization. A possible explanation for these findings has recently emerged. Exposure of cultured rat 
astrocytes (the cells that express GS in the brain) to pathophysiologically relevant (low millimolar) concentrations of 
ammonia results in significant nitration of GS on the tyrosine residues [18] leading to a significant reduction of GS 
activity. Whether, or not similar mechanisms are responsible for the loss of brain GS expression in ALF awaits the 
results of ongoing studies. These findings of a lack of induction of brain GS in ALF again underscores the brain's lack 
of an adequate protective mechanism against ammonia toxicity. 
In conclusion, ALF resulting from hepatic devascularization in the rat results in an early increase in GS activity in 
skeletal muscle, an increase that results from post-transcriptional change in GS protein. Spectroscopic studies 
confirm that this increase in activity results in increased de novo synthesis of glutamine in the muscle and studies of 
arterio-venous differences corrected for muscle blood flow reveal significant increases of muscle glutamine release. 
Initial studies suggest that similar mechanisms occur in ALF patients. If confirmed, these findings suggest that the 
maintenance of skeletal muscle mass and the use of agents with the potential to stimulate GS activity in skeletal 
muscle could be useful in the reduction of circulating ammonia and the prevention of the cerebral complications of 
ALF. 
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